Skip to main content
. 2020 Jul 16;106(8):2131–2146. doi: 10.3324/haematol.2019.242990

Figure 8.

Figure 8.

Tauroursodeoxycholic acid leads to a reduction of acute graft-versus-host disease. A model, in which this positive effect is achieved by two distinct mechanisms: enhancing the viability during exposure to pro-inflammatory cytokines and reduction of antigen presentation in the intestine with a consequent decrease in apoptosis.